Hrt Financial LP Fate Therapeutics Inc Transaction History

Hrt Financial LP

$15.7 Billion
Q4 2024

A detailed history of Hrt Financial LP transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Hrt Financial LP holds 29,173 shares of FATE stock, worth $32,673. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,173

Previous 209,144 86.05%

Holding current value

$32,673

Previous $732,000 93.44%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$1.61 - $3.35 $289,753 - $602,902	-179,971 Reduced 86.05%	29,173 $48,000
Q3 2024 Nov 12, 2024	BUY	$3.12 - $5.57 $468,368 - $836,157	150,118 Added 254.33%	209,144 $732,000
Q2 2024 Aug 12, 2024	BUY	$3.26 - $7.08 $192,424 - $417,904	59,026 New	59,026 $193,000
Q4 2023 Feb 09, 2024	SELL	$1.65 - $3.94 $457,936 - $1.09 Million	-277,537 Reduced 41.22%	395,753 $1.48 Million
Q3 2023 Nov 13, 2023	BUY	$2.02 - $5.04 $831,591 - $2.07 Million	411,679 Added 157.36%	673,290 $1.43 Million
Q2 2023 Aug 11, 2023	BUY	$4.76 - $6.59 $1.25 Million - $1.72 Million	261,611 New	261,611 $1.25 Million
Q4 2022 Feb 10, 2023	SELL	$9.86 - $23.83 $672,550 - $1.63 Million	-68,210 Reduced 64.27%	37,915 $382,000
Q3 2022 Nov 14, 2022	BUY	$21.04 - $36.06 $2.23 Million - $3.83 Million	106,125 New	106,125 $2.38 Million
Q4 2021 Feb 14, 2022	SELL	$47.84 - $64.34 $2.72 Million - $3.66 Million	-56,876 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$59.27 - $95.73 $3.38 Million - $5.46 Million	-57,067 Reduced 50.08%	56,876 $3.37 Million
Q2 2021 Aug 16, 2021	BUY	$67.25 - $92.52 $7.66 Million - $10.5 Million	113,943 New	113,943 $9.89 Million
Q1 2021 May 17, 2021	SELL	$72.16 - $117.4 $1.17 Million - $1.91 Million	-16,241 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$38.09 - $100.95 $618,619 - $1.64 Million	16,241 New	16,241 $1.48 Million
Q4 2019 Feb 14, 2020	SELL	$13.39 - $20.73 $382,994 - $592,940	-28,603 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$15.47 - $22.5 $442,488 - $643,567	28,603 New	28,603 $444,000
Q4 2018 Feb 15, 2019	SELL	$11.48 - $16.98 $411,500 - $608,648	-35,845 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$8.75 - $16.29 $313,643 - $583,915	35,845 New	35,845 $583,000

Others Institutions Holding FATE

# of Institutions

167

Shares Held

101M

Call Options Held

41.3K

Put Options Held

15.9K

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $109M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account